Biomarkers of response previously explored include angiopoietin-2 (ANGPT2) in melanoma and polybromo-1 (PBRM1) and polybromo-associated barrier-to-autointegration factor (PBAF) in renal cell carcinoma (RCC) [6, 15]. Here, PBRM1 is linked to melanoma.